WHO ICTRP trial
Neurostimulation for the treatment of mild cognitive impairment in Parkinson*s…
NL-OMON56853 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON56853 |
|---|---|
| Public title | Neurostimulation for the treatment of mild cognitive impairment in Parkinson*s disease: an acceptability cross-over study |
| Scientific title | Neurostimulation for the treatment of mild cognitive impairment in Parkinson*s disease: an acceptability cross-over study - NESCIO-PD |
| Primary sponsor | Amsterdam UMC |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Countries | Netherlands |
| Conditions | cognitive impairment thinking problems;10028037;10012272 |
| Interventions | Participants will undergo four consecutive phases: 1) a no-intervention baseline condition, 2) 12 sessions of 20-minute repetitive transcranial magnetic stimulation (rTMS) (10Hz) or anodal transcranial direct current stimulation (tDCS)… |
| Registration date | May 31, 2024 |
| Target size | 20 |
| Secondary IDs | NL84843.018.23 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: